Craft

genOway

Stock Price

€3.5

2024-10-29

Market Capitalization

€28.3 M

2024-10-29

Revenue

€22.1 M

FY, 2024

genOway Summary

Company Summary

Overview
genOway is a biotechnology company that provides preclinical models and solutions to biopharmaceutical companies and academic institutions. Its offering includes immunodeficient rodents, humanized mice, cell lines, conditional knockout mice, and mouse and rat model generation.
Type
Public
Status
Active
Founded
1999
HQ
Lyon, FR | view all locations
Website
https://www.genoway.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Alexandre Fraichard

    Alexandre Fraichard, Founder, CEO & GM

  • Christian Grenier, Chairman of the Board

    • Andre Tartar, Director

      • Laurent Fraisse, Director

        LocationsView all

        1 location detected

        • Lyon, Auvergne-Rhône-Alpes HQ

          France

          31 Rue Saint-Jean-de-Dieu

        genOway Financials

        Summary Financials

        Revenue (H1, 2025)
        €9.6M
        Gross profit (H1, 2025)
        €10.2M
        Net income (H1, 2025)
        €162.0K
        Cash (H1, 2025)
        €2.1M
        EBIT (H1, 2025)
        €195.0K
        Enterprise value
        $40.6M

        Footer menu